BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Upsher-Smith Laboratories, LLC Selects PANTHERx® Rare for the Distribution of TORPENZ™ (everolimus) Tablets

  August 20, 2024

   · 

  9 min read
• News

  Novartis celebrates Canada-wide implementation of newborn screening for spinal muscular atrophy

  August 20, 2024

   · 

  3 min read
• Business

  Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting

  August 20, 2024

   · 

  7 min read
• News

  Tectonic Therapeutic to Participate in September Investor Conferences

  August 20, 2024

   · 

  2 min read
• Press Releases

  TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma

  August 20, 2024

   · 

  16 min read
• Press Releases

  Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 19, 2024

  August 20, 2024

   · 

  1 min read
• Press Releases

  Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

  August 20, 2024

   · 

  7 min read
• Press Releases

  Kymera Therapeutics Announces Proposed Public Offering - August 19, 2024

  August 20, 2024

   · 

  5 min read
• Press Releases

  Kymera Therapeutics Announces Pricing of $225 Million Public Offering

  August 20, 2024

   · 

  6 min read
• Press Releases

  China’s National Medical Products Administration (NMPA) Approves PADCEV™ (enfortumab vedotin) for Treatment of Locally Advanced or Metastatic Urothelial Cancer

  August 20, 2024

   · 

  13 min read